Network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema
Aim: With no head-to-head studies comparing the effectiveness of lanadelumab and berotralstat for prevention of hereditary angioedema (HAE) attacks, this networkmeta-analysis (NMA) aimed to indirectly compare the effectiveness of these treatments. Materials & methods: The NMA, using the publishe...
Saved in:
Main Authors: | Maureen Watt (Author), Mia Malmenas (Author), Dorothy Romanus (Author), Katrin Haeussler (Author) |
---|---|
Format: | Book |
Published: |
Becaris Publishing Limited,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Letter in reply: network meta-analysis for indirect comparison of lanadelumab and for the treatment of hereditary angioedema
by: Maureen Watt, et al.
Published: (2024) -
Letter to the editor: network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema
by: Max Schlueter, et al.
Published: (2024) -
Indirect Comparison of Lanadelumab and Intravenous C1-INH Using Data from the HELP and CHANGE Studies: Bayesian and Frequentist Analyses
by: Joan Mendivil, et al.
Published: (2021) -
Population pharmacokinetic modeling and simulations of berotralstat for prophylactic treatment of attacks of hereditary angioedema
by: Amanda Mathis, et al.
Published: (2022) -
Prevention of Recurrent Attacks of Hereditary Angioedema (HAE): Berotralstat and Its Oral Bioavailability
by: Diaz-Menindez M, et al.
Published: (2023)